INCYTE CORP - INCY
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Apr 02, 2026 | — | A | A | 269.0 | 94.12 | 25,318.28 | 21,122.0 | View | |
| Apr 02, 2026 | — | A | A | 421.0 | 0.0 | 0.0 | 28,188,718.0 | View | |
| Apr 02, 2026 | — | A | A | 421.0 | 0.0 | 0.0 | 2,818,039.0 | View | |
| Apr 02, 2026 | — | A | A | 265.0 | 94.12 | 24,941.8 | 23,741.0 | View | |
| Mar 26, 2026 | EVP, GM, Dermatology US | F | D | 537.0 | 92.23 | 49,527.51 | 14,882.0 | View | |
| Mar 19, 2026 | President, R&D | M | D | 11,501.0 | 0.0 | 0.0 | 32,910.0 | View | |
| Mar 19, 2026 | President, R&D | M | D | 7,166.0 | 0.0 | 0.0 | 9,102.0 | View | |
| Mar 19, 2026 | President, R&D | S | D | 18,667.0 | 94.24 | 1,759,178.08 | 234,800.0 | View | |
| Mar 19, 2026 | President, R&D | M | A | 11,501.0 | 64.25 | 738,939.25 | 253,467.0 | View | |
| Mar 19, 2026 | President, R&D | M | A | 7,166.0 | 61.18 | 438,415.88 | 241,966.0 | View | |
| Feb 23, 2026 | President, R&D | M | D | 5,575.0 | 0.0 | 0.0 | 16,268.0 | View | |
| Feb 23, 2026 | President, R&D | M | D | 13,093.0 | 0.0 | 0.0 | 7,182.0 | View | |
| Feb 23, 2026 | President, R&D | S | D | 18,668.0 | 100.91 | 1,883,787.88 | 234,800.0 | View | |
| Feb 23, 2026 | President, R&D | M | A | 5,575.0 | 61.18 | 341,078.5 | 253,468.0 | View | |
| Feb 23, 2026 | President, R&D | M | A | 13,093.0 | 61.76 | 808,623.68 | 247,893.0 | View | |
| Feb 04, 2026 | EVP, Head of Tech. Operations | F | D | 185.0 | 102.67 | 18,993.95 | 34,065.0 | View | |
| Feb 04, 2026 | EVP, Head of Incyte Intl | F | D | 111.0 | 102.67 | 11,396.37 | 38,041.0 | View | |
| Jan 21, 2026 | EVP, Head of Tech. Operations | F | D | 429.0 | 102.62 | 44,023.98 | 34,250.0 | View | |
| Jan 21, 2026 | EVP, Head of Tech. Operations | A | A | 7,426.0 | 0.0 | 0.0 | 34,679.0 | View | |
| Jan 21, 2026 | EVP & Chief Scientific Officer | A | A | 4,218.0 | 0.0 | 0.0 | 4,218.0 | View | |
| Jan 21, 2026 | Principal Accounting Officer | A | A | 2,425.0 | 0.0 | 0.0 | 2,425.0 | View | |
| Jan 21, 2026 | EVP, GM, Dermatology US | A | A | 8,542.0 | 0.0 | 0.0 | 8,542.0 | View | |
| Jan 21, 2026 | EVP, Head of US Oncology | A | A | 14,237.0 | 0.0 | 0.0 | 14,237.0 | View | |
| Jan 21, 2026 | EVP & Chief Medical Officer | A | A | 19,932.0 | 0.0 | 0.0 | 19,932.0 | View | |
| Jan 21, 2026 | President, R&D | A | A | 28,475.0 | 0.0 | 0.0 | 28,475.0 | View | |
| Jan 21, 2026 | EVP, Head of Incyte Intl | A | A | 8,911.0 | 0.0 | 0.0 | 38,152.0 | View | |
| Jan 08, 2026 | EVP, Head of US Oncology | S | D | 10,856.0 | 109.07 | 1,184,063.92 | 66,132.0 | View | |
| Jan 08, 2026 | EVP, Head of US Oncology | F | D | 8,264.0 | 106.66 | 881,438.24 | 76,988.0 | View | |
| Jan 07, 2026 | EVP & Chief Medical Officer | S | D | 15,634.0 | 101.7 | 1,589,977.8 | 34,203.0 | View | |
| Jan 05, 2026 | — | A | A | 328.0 | 0.0 | 0.0 | 28,188,297.0 | View | |
| Jan 05, 2026 | — | A | A | 328.0 | 0.0 | 0.0 | 2,817,618.0 | View | |
| Jan 05, 2026 | EVP, Head of Tech. Operations | F | D | 254.0 | 98.77 | 25,087.58 | 27,253.0 | View | |
| Jan 05, 2026 | EVP & Chief Medical Officer | F | D | 13,292.0 | 98.77 | 1,312,850.84 | 49,837.0 | View | |
| Jan 05, 2026 | — | A | A | 245.0 | 98.77 | 24,198.65 | 20,853.0 | View | |
| Jan 05, 2026 | — | A | A | 241.0 | 98.77 | 23,803.57 | 23,476.0 | View | |
| Dec 22, 2025 | Principal Accounting Officer | M | D | 1,730.0 | 0.0 | 0.0 | 0.0 | View | |
| Dec 22, 2025 | Principal Accounting Officer | M | D | 1,044.0 | 0.0 | 0.0 | 0.0 | View | |
| Dec 22, 2025 | Principal Accounting Officer | S | D | 2,774.0 | 100.0 | 277,400.0 | 22,973.0 | View | |
| Dec 22, 2025 | Principal Accounting Officer | M | A | 1,730.0 | 95.76 | 165,664.8 | 25,747.0 | View | |
| Dec 22, 2025 | Principal Accounting Officer | M | A | 1,044.0 | 95.76 | 99,973.44 | 24,017.0 | View | |
| Dec 22, 2025 | Principal Accounting Officer | S | D | 600.0 | 98.25 | 58,950.0 | 22,973.0 | View | |
| Dec 18, 2025 | EVP, Head of Tech. Operations | S | D | 4,323.0 | 97.26 | 420,454.98 | 27,507.0 | View | |
| Dec 18, 2025 | EVP, Head of Tech. Operations | S | D | 53,175.0 | 97.29 | 5,173,395.75 | 31,830.0 | View | |
| Dec 18, 2025 | EVP, Head of Tech. Operations | S | D | 833.0 | 97.42 | 81,150.86 | 85,005.0 | View | |
| Dec 12, 2025 | EVP & Chief Scientific Officer | S | D | 255.0 | 94.94 | 24,209.7 | 60,011.0 | View | |
| Dec 12, 2025 | EVP & Chief Scientific Officer | S | D | 5,553.0 | 95.58 | 530,755.74 | 60,266.0 | View | |
| Dec 10, 2025 | — | F | D | 2,843.0 | 96.7 | 274,918.1 | 326,803.0 | View | |
| Dec 03, 2025 | EVP, Head of Tech. Operations | F | D | 326.0 | 102.04 | 33,265.04 | 85,838.0 | View | |
| Dec 03, 2025 | EVP & Chief Medical Officer | S | D | 20,105.0 | 102.51 | 2,060,963.55 | 63,129.0 | View | |
| Dec 03, 2025 | EVP & Chief Medical Officer | F | D | 17,093.0 | 102.04 | 1,744,169.72 | 83,234.0 | View | |
| Dec 03, 2025 | EVP & Chief Medical Officer | S | D | 2,559.0 | 102.96 | 263,474.64 | 100,327.0 | View | |
| Dec 03, 2025 | EVP & General Counsel | A | A | 23,665.0 | 0.0 | 0.0 | 23,665.0 | View | |
| Dec 03, 2025 | EVP & General Counsel | A | A | 43,301.0 | 0.0 | 0.0 | 43,301.0 | View | |
| Dec 03, 2025 | EVP & General Counsel | A | A | 9,466.0 | 0.0 | 0.0 | 9,466.0 | View | |
| Nov 25, 2025 | Principal Accounting Officer | S | D | 600.0 | 103.0 | 61,800.0 | 23,573.0 | View | |
| Nov 25, 2025 | Principal Accounting Officer | S | D | 169.0 | 102.0 | 17,238.0 | 24,173.0 | View | |
| Nov 19, 2025 | EVP & General Counsel | M | D | 278.0 | 0.0 | 0.0 | 8,883.0 | View | |
| Nov 19, 2025 | EVP & General Counsel | S | D | 278.0 | 104.36 | 29,012.08 | 26,569.0 | View | |
| Nov 19, 2025 | EVP & General Counsel | M | A | 278.0 | 64.25 | 17,861.5 | 26,847.0 | View | |
| Nov 12, 2025 | — | S | D | 187,500.0 | 105.46 | 19,773,750.0 | 329,646.0 | View | |
| Nov 07, 2025 | EVP & Chief Medical Officer | M | D | 1,044.0 | 0.0 | 0.0 | 0.0 | View | |
| Nov 07, 2025 | EVP & Chief Medical Officer | M | D | 2,995.0 | 0.0 | 0.0 | 0.0 | View | |
| Nov 07, 2025 | EVP & Chief Medical Officer | M | D | 1,194.0 | 0.0 | 0.0 | 0.0 | View | |
| Nov 07, 2025 | EVP & Chief Medical Officer | S | D | 5,233.0 | 102.2 | 534,812.6 | 102,886.0 | View | |
| Nov 07, 2025 | EVP & Chief Medical Officer | M | A | 1,044.0 | 95.76 | 99,973.44 | 108,119.0 | View | |
| Nov 07, 2025 | EVP & Chief Medical Officer | M | A | 2,995.0 | 95.76 | 286,801.2 | 107,075.0 | View | |
| Nov 07, 2025 | EVP & Chief Medical Officer | M | A | 1,194.0 | 83.83 | 100,093.02 | 104,080.0 | View | |
| Nov 06, 2025 | EVP & General Counsel | M | D | 598.0 | 0.0 | 0.0 | 13,765.0 | View | |
| Nov 06, 2025 | EVP & General Counsel | S | D | 598.0 | 101.36 | 60,613.28 | 26,569.0 | View | |
| Nov 06, 2025 | EVP & General Counsel | M | A | 598.0 | 58.06 | 34,719.88 | 27,167.0 | View | |
| Nov 05, 2025 | EVP, Head of Incyte Intl | S | D | 3,074.0 | 94.02 | 289,017.48 | 29,241.0 | View | |
| Oct 17, 2025 | EVP & General Counsel | M | D | 277.0 | 0.0 | 0.0 | 9,161.0 | View | |
| Oct 17, 2025 | EVP & General Counsel | S | D | 277.0 | 85.13 | 23,581.01 | 26,569.0 | View | |
| Oct 17, 2025 | EVP & General Counsel | M | A | 277.0 | 64.25 | 17,797.25 | 26,846.0 | View |